Flow Space - Survey: 90% Want Alzheimer's Blood Tests, 9% of Doctors Ask (Jul 2026)

Tier 2: Professional organization or credentialed expert guidance
Publisher: Flow Space (survey: Harris Poll for HealthyWomen) · Published: July 27, 2026 · Accessed: August 15, 2026

Visit the source ↗

Claims this source supports

• 90% of women ages 45-64 said they would be open to a simple blood test that could help diagnose Alzheimer's disease early; only 9% said a healthcare provider had spoken with them about cognitive health (Harris Poll for HealthyWomen, reported by Flow Space, Jul 27 2026).
• One in four respondents said they had already noticed changes in their memory or thinking; one in three reported a family history of Alzheimer's or dementia.
• 91% said cognitive screening should be as routine as a mammogram or cholesterol test; 94% said an early diagnosis would give them more time to explore treatment options.
• Only 13% of respondents were familiar with FDA-cleared Alzheimer's blood tests. Nearly two-thirds of Americans living with Alzheimer's are women, but two in three respondents did not know women are more likely than men to develop the disease.
• The FDA cleared the first blood test used to help diagnose Alzheimer's in May 2025; it measures biomarkers associated with amyloid plaques and is intended for adults 55 and older already experiencing signs or symptoms of cognitive decline - not as a routine screening test for people without symptoms.
• The U.S. Preventive Services Task Force's current guidance (issued 2020, being updated) found insufficient evidence to recommend for or against routinely screening asymptomatic adults 65 and older for cognitive impairment.
• Stanford Medicine neurologists quoted in the piece say dementia risk should not currently drive decisions about hormone therapy; the estrogen-MHT and dementia relationship remains unresolved.